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The major histocompatibility complex (MHC) 1 -linked immune response (lr) genes 
control the capacity of an animal to mount a T  cell-dependent immune response and 
are closely linked  to genes that  code for a  group of cell surface antigens  termed I 
region-associated (Ia)  antigens  (1).  Alloantibodies to Ia antigens have proven to be 
extremely useful tools in defining the relationship between Ia antigens and lr gene 
product function (2). Studies of the effects of anti-Ia antibody on T  cell-proliferative 
responses in vitro have suggested that the Ia antigens themselves are the products of 
the lr genes. Thus, it was initially demonstrated in the guinea pig (3) and later in the 
mouse (4) that the capacity of F1 macrophages to present antigens to (nonresponder 
×  responder)F] T  cells can be blocked by anti-Ia antibodies specific for antigens of 
the  responder  parent,  but  not  by  anti-Ia  antibodies  specific  for  antigens  of the 
nonresponder parent. 
Antibodies raised  by cross-immunization of different strains within a  species are 
restricted  in  their  specificity  to  polymorphic  determinants  varying  between  the 
individual  strains.  Nonpolymorphic regions on  Ia  antigens  can  be  recognized by 
xenoantisera. The recently introduced hybridoma technique of K6hler and Milstein 
(5) provides a tool for the production of monoclonal xenogeneic antibodies and allows 
one to dissect the immune response to a complex antigen into its individual compo- 
nents.  We  have  prepared  a  number  of monoclonal  antibodies  to  guinea  pig  Ia 
antigens. 2 Hybrids were obtained after immunization of BALB/c mice with Ia-positive 
EN-L2C leukemia cells of strain 2 guinea pigs and fusion of spleen cells to the NS-1 
myeloma line. The secreted antibodies detected either alloantigenic determinants of 
strain 2 Ia antigens or common determinants present on both guinea pig strain 2 and 
strain  13 Ia antigens. In this report, the individual monoclonal antibodies were tested 
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for  their  inhibitory  effects  on  antigen-,  alloantigen-,  and  mitogen-induced  T  cell 
proliferation. The data demonstrate that monoclonal anti-Ia antibodies are as capable 
of inhibiting T-cell activation by these stimuli as alloantibodies  to Ia antigens raised 
by cross-immunization of inbred strain 2 and strain  13 animals. In addition, a detailed 
analysis  of the  effects  of a  single  monoclonal  antibody  on  the  responses  to several 
antigens demonstrated a  selective pattern of inhibition  in that the responses to some, 
but  not  all,  antigens  were  inhibited.  These  results  suggest  that  monoclonal  anti-Ia 
antibodies  may  be  able  to  discriminate  between  functionally  different  regions  on 
individual  Ia molecules involved in antigen presentation. 
Materials  and Methods 
Animals.  Inbred strain  2, strain  13, and  (strain  2 X strain  13)Fa [(2  ×  13)F1] guinea pigs 
were obtained  from the Division of Research Services,  National  Institutes of Health  (NIH), 
Bethesda, Md. 
Monoclonal Antibodies to Guinea Pig Ia Antigens.  The  production  of monoclonal antibodies 
directed  to guinea pig Ia antigens  and  their  properties  is  described  in  detail  elsewhere, z A 
hybrid myeloma line provided by Ms. R. Lieberman, NIH, which secreted an IgM antibody 
directed to inulin in addition to the parental  (y~, K) antibody of the P3X63 Ag8 myeloma line, 
was used for the production of a control ascites. In all experiments, this control ascitic fluid was 
used in parallel to exclude any nonspecific effects. 
Alloantibodies to Ia Antigens.  A strain  13 anti-strain 2 serum (anti-Ia.2,4) and a strain 2 anti- 
strain  13 serum (anti-Ia. 1,3,7) were prepared as described previously (6). 
Antigens.  A copolymer of e-glutamic acid (60%) and L-lysine (40%) (GL), with an average 
40,000 mol wt, was purchased from New England Nuclear, Boston, Mass. Ovalbumin (OVA) 
and a  copolymer of L-glutamie acid  (50%) and  L-tyrosine (50%) (GT),  14,500  mol wt, were 
purchased  from  Miles  Laboratories,  Inc.,  Miles  Research  Division,  Kankakee,  Ill.  Purified 
protein  derivative  of tuberculin  (PPD)  was  purchased  from Connaught  Medical  Research 
Laboratory,  Willowdale,  Ontario,  Canada.  2,4-dinitrophenyl  (DNP)-GL  was  prepared  as 
described by Janeway and Paul (7). 
Immunizations.  Solutions of each antigen in saline were emulsified with an equal volume of 
complete Freund's adjuvant (CFA) that contained 0.4 mg/ml Mycobacterium tuberculosis H37Ra 
(Difco Laboratories, Detroit, Mich.). Each animal received 0.1 ml of emulsion in each footpad. 
Strain 2 animals received a total of 100/tg of DNP-GL and  100/~g of OVA; strain  13 animals 
received  100/xg of OVA and 500/~g of GT. 
Preparatwn of Peritoneal Exudate Cells and  T  Lymphocytes.  2-4  wk  after  immunization,  the 
animals were injected intraperitoneally with 25 ml of sterile mineral oil  (Marcol 52;  Humble 
Oil & Refining Co., Houston, Tex.). 4 d later, the resulting peritoneal exudate was harvested. 
This cell population consisted of-75% macrophages, 10% granulocytes, and 15% lymphocytes. 
Peritoneal exudate lymphocytes (PEL) were obtained by passing the peritoneal exudate cells 
(PEC) over a rayon-wool-adherence column (8). The resulting cell population was composed of 
80-90% T  lymphoeytes,  10-20%  macrophages,  and  <5%  B  lymphocytes. Enriched column- 
purified T lymphocytes from lymph nodes (LNL) were obtained by passing cells of the regional 
lymph nodes of immunized guinea pigs over a  rayon-wool column  (8). This cell  population 
consisted of 85-95% T  lymphocytes and  10-t5% B lymphocytes. 
Proliferative Response of Immune T Lymphocytes to Soluble Protein Antigens or to Mitogen.  Antigen- 
or mitogen-induced proliferation of antigen-primed T  cells was measured by incubation with 
antigen- or mitogen-pulsed maerophages. RPMI-1640 medium (Grand Island Biological Co., 
Grand Island, N. Y.) that contained L-glutamine (300 ~g/ml), penicillin  (100 U/ml), strepto- 
mycin (100/.tg/ml), 5-fluorocytosine (1 ~g/ml), 2-mercaptoethanol (5 ×  10  -5 M), and 10% heat- 
inactivated fetal  calf serum  (FCS) was used.  For antigen or mitogen pulsing, unfractionated 
mineral  oil-induced  PEC  (10  ×  106/ml)  from  nonimmune  guinea  pigs  were  incubated  in 
RPMI-1640 medium at 37°C for 1 h in the presence of 25/~g/ml mitomycin C (Sigma Chemical 
Co., St.  Louis, Mo.)  and  100/tg OVA, DNP-GL, GT,  PPD, or phytohemagglutinin  (PHA) 
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remove unbound antigen or mitogen. These antigen- or mitogen-pulsed PEC  (1  ×  l0  s) were 
incubated in 0.2 ml of medium with PEL (1 X  10 -2 ×  10S) from an immunized animal for 4 
d  in round-bottomed microtiter plates (Linbro Chemical Company, New Haven, Conn.).  1.0 
~Ci of tritiated thymidine ([aH]TdR) (6.7 Ci/mM sp act; New England Nuclear) was added to 
each well  18 h  before harvesting, and the amount of radioactivity incorporated into cellular 
DNA was  determined  with  the  aid  of a  semiautomated  microharvesting  device  Mash  II, 
Microbiological Associates, Walkersville, Md. The results of triplicate cultures are expressed as 
total counts per minute/culture or as counts per minute with antigen-pulsed PEC -  counts per 
minute with unpulsed  PEC  (Acpm). The SEM of triplicate  samples was never >10% of the 
mean,  and  for simplicity,  only  the  mean  of triplicate  samples  is  reported  in  the  various 
proliferation assays. 
Mixed Leukocyte Reaction (MLR).  Mitomycin-treated PEC (l  X  105) were cultured  for 6 d 
with rayon-wool-purified LNL (3 ×  10  r) in flat-bottomed microtiter plates in 0.2 ml of medium 
that  contained  5%  heat-inactivated  normal  guinea  pig  serum  (NGPS)  or  FCS.  [aH]TdR 
incorporation was measured as described above. 
Results 
Reactivity of the Monoclonal Antibodies with the I Subregions of Strain 2 and Strain 13 Guinea 
Pigs.  To facilitate  the interpretation  of the studies to be presented  on the effects of 
the  monoclonal  antibodies  on T  lymphocyte function,  we will  first  summarize  the 
results of our serologic and biochemical studies 2 on the reactivity of the monoclonal 
anti-Ia antibodies with the different I subregions of strain 2 and strain  13 guinea pigs. 
The I  region of the MHC  of strain  2  animals has been divided  into two or possibly 
three subregions (9). The Ia.2 antigen was present on a  molecule in which the 33,000- 
and 25,000-dahon chains were noncovalently associated, whereas the Ia.4,5 antigens 
were found on a distinct molecule in which the 33,000- and 25,000-dahon chains were 
linked by disulfide bonds;  the subregion assignment of Ia.6 has not been made; and 
the  existence  of a  third  subregion  in  strain  2  animals  was  inferred  from  the  data 
obtained  from strain  13 guinea pigs. All four monoclonal were cytolytic for strain  2 
cells  at  dilutions  as  high  as  1/10,000.  Monoclonal  antibody~  22C4  wa.s  shown  in 
immunoprecipitation  studies  to react  with  the  Ia.2-bearing  molecule  as well  as the 
molecule  that  bore  Ia.4,5;  in  contrast,  27E7  was  shown  in  sequential  precipitation 
studies  to  react  only  with  the  Ia.2-bearing  and  not  the  Ia.4,5-bearing  molecule. 
Monoclonals  25E3 and  25E11  were shown in a  radioactive binding study with  12sI- 
labeled F(ab')2 rabbit anti-mouse Ig to react with alloantigenic determinants of strain 
2 Ia antigens in that they failed to react with strain  13 cells and that their binding to 
strain  2  cells  could  be  inhibited  by  13  anti-2  serum  (anti-Ia.2,4);  however,  as they 
were  inactive  in  immunoprecipitation  studies,  we could  not  specifically  determine 
against which/-subregion of the strain 2/-region they were reactive. 
The  strain  13  I  region  can  be  divided  into  three  subregions:  the  Ia.3,5  antigens 
were  found on a  molecule  in  which  the  33,000-  and  25,000-dahon  chains were not 
covalently associated, whereas Ia.7 was present on a molecule in which the two chains 
were covalently linked,  and  Ia.l,6  was  found on  a  single chain  molecule of 26,000 
dahons. Of the two monoclonals reactive with strain  13 cells  (22C4 and 27E7), only 
one,  22C4,  was  cytolytic in  the  presence  of complement.  However,  both  27E7  and 
22C4  could  be  shown  to  react  with  the  products  of all  three  subregions  because 
preprecipitation  of all-labeled  extracts  of strain  13  cells with either of these  mono- 
clonals removed all reactivity for 2 anti-13 serum  (anti-Ia. 1,3,7). 
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antigens inhibit T  lymphocyte proliferation induced by allogeneic macrophages (10). 
The  four  monoclonal  antibodies  (22C4,  25E3,  25E11,  and  27E7)  to  guinea  pig  Ia 
antigens were compared with alloantibodies  for-inhibition of the MLR. LNL of one 
strain  were  cultured  for  6  d  with  mitomycin  C-treated  syngeneic  or  allogeneic 
macrophages.  Ascitic  fluids  produced  from  the  individual  hybrid  cell  lines  or  the 
control ascites were diluted  in heat-inactivated  NGPS and added  to the cultures  to 
give a  final serum concentration of 5%. The antibody dilution given in the Tables or 
Figures  represents  the  final  dilution  of the  ascitic  fluids  in  the  culture.  [3H]TdR 
incorporation was determined  in parallel cultures in the presence of NGPS alone,  13 
anti-2, or 2 anti-13 alloantisera. 
The results of a representative experiment are shown in Table I. All four monoclonal 
anti-Ia  antibodies  inhibited  the  MLR  when  strain  2  macrophages  were  used  as 
stimulator  cells  and  strain  13  LNL as  responder  cells.  In contrast,  only antibodies 
22C4 and 27E7 inhibited the MLR between strain 2 LNL as responder and strain  13 
macrophages as stimulator cells. The control ascitic fluid in a number of proliferation 
experiments  never  exhibited  any  significant  inhibitory  effects.  The  experiment  in 
Table I was performed at a  1/100 final dilution of the four monoclonal antibodies.  In 
several  experiments  of  this  type  performed  at  this  dilution  of  ascites,  [3H]TdR 
incorporation was inhibited  by 50-70%. However, the inhibitory effect of the mono- 
clonal  antibodies  on  the  MLR  was  rapidly  lost  upon  further  dilution  and  was  no 
longer present at a dilution of 1/800. Mixing of the monoclonal antibodies in different 
combinations while maintaining the same final antibody concentration in the cultures 
did not result in any additional  inhibitory effects. The observed inhibitory pattern in 
the  MLR  parallels  the  reactivity  of the  corresponding  antibodies  in  binding  or 
immunoprecipitation experiments. All four antibodies were shown to react with strain 
2 Ia antigens, and all inhibited  the MLR  using strain  2 macrophages as stimulators. 
On  the  other  hand,  only  22C4  and  27E7,  which  proved  to  recognize  common 
determinants  present  on both  strain  13  and  strain  2  Ia antigens,  also inhibited  the 
strain  2  LNL  proliferative  response  to  strain  13  macrophages.  The  unidirectional 
inhibition  of  the  MLR  by  25E3  and  25Ell,  which  reacted  with  alloantigenic 
TAnLE I 
Inhibition of the MLR by Monoclonal Anti-Ia Antibody 
13">2:]:  2> 13  13> 13  2>2 
cprn 
22C4  43,042  37,981  1,953  768 
25E3  47,942  68,765  1,906  2,030 
25E11  51,838  64,425  788  2,113 
27 E7  48,288  22, 713  621  789 
Control ascites  98,076  64,759  1,402  1,264 
NGPS  105,423  71,840  953  1,424 
2 anti- 13  106,423  8,000  835  1,437 
13 anti-2  30,961  65,000  994  1,291 
LNL (3 ×  10  r') were cultured with syngeneic or allogeneic PEC (1 ×  10  r') for 5 d in the presence of a 
1/100 dilution of ascites or alloantibody. Results are expressed as counts per minute [3H]TdR incorpo- 
ration. Results in italics represent significant inhibition. 
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determinants of strain 2 Ia molecules, confirms with monoclonal reagents that anti-Ia 
antibodies  specific  for  the  stimulator  cells  and  not  for  the  responder  cells  inhibit 
alloantigen-induced T  cell proliferation. 
The  Effect  of the  Monoclonal  Anti-Ia  Antibodies  on  the  Antigen-  and  Mitogen-induced 
Proliferative Response of Strain 2 PEL.  The proliferative response of PEL to stimulation 
by  a  large  number  of antigens  in  vitro  is  markedly  depressed  in  the  presence  of 
alloantisera directed to Ia antigens (11). The xenogeneic monoclonal anti-Ia antibodies 
were similarly tested  for their inhibitory activity on T  lymphocyte proliferation.  As 
the antibody-secreting hybrid cell lines were produced after immunization with strain 
2 cells,  they were first tested for their effect on antigen- or mitogen-induced prolifer- 
ation of strain 2 PEL in vitro. PEL from immune strain 2 guinea pigs were cultured 
with antigen-pulsed macrophages for 3 d  in the presence of 10% FCS that contained 
the  monoclonal  anti-Ia  antibodies  or  the  control  ascites  at  different  dilutions.  A 
typical concentration-dependent inhibition of the PPD-induced proliferative response 
by monoclonal antibodies 22C4 and 27E7 is shown in  Fig.  1.  Significant inhibition 
was seen at dilutions of 1/2,500. In contrast, antibodies 25E3 and 25E11 had little, if 
any, effect on the PPD-induced proliferative response of strain  2 PEL. The prolifer- 
ative response in the presence of the control ascites even at a high concentration (1/30 
final dilution in culture)  was in the range of the control culture that contained FCS 
alone.  The background proliferation  in the absence of PPD was approximately the 
same in FCS or in ascites-containing cultures. 
The effect  of the  monoclonal anti-Ia antibodies  on  the  proliferative  response of 
strain 2 PEL to the antigens OVA and GL and the mitogen PHA was then tested. GL 
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FIO.  I.  Dose-dependent  inhibition of the proliferative response of strain 2 PEL to PPD-pulsed 
macrophages by monoclonal  anti-la antibody. Strain 2 PEL (2 × l0  ~) were cultured with syngeneic 
PEC (l  X  I0  r) in the presence of different dilutions of the anti-la antibodies. Results are expressed 
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is  an  antigen,  the  response to which  is controlled by an  Ir gene linked  to the  Ia.2 
antigen of the strain  2 MHC  (9),  whereas the responses to OVA, PPD, or PHA are 
not under unigenic Ir gene control. In a  few experiments, DNP-GL was used instead 
of nonsubstituted GL and gave the same results as GL. Table II represents a  typical 
result  obtained in a  large number of experiments.  All cultures contained  10%  FCS 
and  a  final  concentration of 1/800 of each  monoclonal antibody.  The effects of a 
1/100 dilution of 13 anti-2 serum on these responses were studied in parallel cultures. 
The proliferative response to GL-pulsed macrophages was significantly inhibited by 
25E3, 25E 11, and 27E7 as well as by 13 anti-2 serum. Surprisingly, monoclonal 22C4, 
which,  as our previous biochemical studies  demonstrated,  reacted  specifically with 
the  Ia.2-bearing  molecule,  failed  to  inhibit  the  proliferative  response  to  GL  to  a 
significant extent. The response to OVA was only slightly (25%) inhibited by all the 
monoclonals tested.  Again, as demonstrated in Fig.  1, monoclonals 22C4 and 27E7, 
but not 25E3 and 25E 11, produced a 60-70% inhibition of the response to PPD. Only 
27E7 produced a  significant  inhibition of the proliferative response to PHA-pulsed 
macrophages. 
The  Effect  of the  Monoclonal  Anti-Ia  Antibodies  on  the  Antigen-  and  Mitogen-induced 
Proliferative  Responses  of Strain  13  PEL.  Although  all  the  monoclonals were  raised 
against strain 2 cells,  antibodies 22C4 and 27E7 were shown to recognize common or 
framework  determinants  of Ia  antigens  present  on  all  strain  13  Ia  molecules.  We 
therefore tested the effects of these antibodies, as well as 25E3, 25E11, and 2 anti-13 
serum on the proliferative response of strain  13 PEL to macrophages pulsed with the 
protein antigens GT, OVA, and PPD, and the mitogen PHA (Table III). As in the 
studies with strain  2  PEL, all cultures were performed in  10%  FCS that  contained 
each monoclonal antibody in a  final dilution of 1/800. The proliferative response to 
GT was sighificantly inhibited by monoclonals 22C4 and 27E7, and both 22C4 and 
27E7 produced a  50-60% inhibition of the response to PPD-pulsed macrophages. As 
expected,  monoclonals  25E3  and  25E1 1,  which  in  both  binding  and  cytotoxicity 
assays were shown to be specific for alloantigenic determinants of  strain 2 Ia molecules, 
failed to produce any inhibition of the responses of strain  13 PEL. 
TheEffect  of the  Monoclonal  Anti-Ia  Antibodies  on  the  Antigen-  and  Mitogen-induced 
TABLE II 
Effect of the Monoclonal Anti-Ia Antibodies on the Proliferative Response of Strain 2 PEL 
Stimulus 
GL  OVA  PPD  PHA 
Acpm 
22C4  28,464  44,144  35,217  112,432 
25E3  9,666  46,907  89,954  89,957 
25E I 1  9,691  45,059  85,678  98,303 
27E7  7,123  38,763  31,219  49,632 
Control ascites  33,740  58,085  101,853  85,897 
FCS  31,050  61,464  91,767  103,939 
13 anti-2  5,697  30,635  49,654  62,170 
PEL (2 X 105) were cultured for 3 d with antigen- or mitogen-pulsed PEC (1 x  t05) in the presence cf a 
1/100 dilution of alloantibody. Results are expressed as Acpm [aH]TdR incorporation. Results in i~alics 
represent significant inhibition. REINHARD BURGER AND ETHAN M.  SHEVACH 
TABLE III 
Effect of Monoclonal Anti-Ia Antibodies on the Proliferative Response of Strain 13 PEL 
1017 
Stimulus 
GT  OVA  PPD  PHA 
Acpm 
22C4  25,167  80,010  59,429  171,998 
25E3  72,805  86,953  105,363  175,409 
25E 11  65,308  81,735  121,875  198,002 
27E7  33,942  32,491  45,555  139,775 
Control ascites  67,786  90,973  132,109  209,339 
FCS  68,992  85,634  121,468  225,333 
2 anti- 13  38,872  41,237  134,369  96,135 
PEL (2 ×  10  ~) were cultured for 3 d with antigen- or mitogen-pulsed PEC (l ×  I0  r') in the presence of a 
1/800 dilution of alloantibody. Results are expressed as Acpm [SH]TdR incorporation. Results in italics 
represent significant inhibition. 
Proliferative Responses of (2  ×  13)Ft PEL.  Anti-Ia sera raised by cross-immunization 
of strain  2 and strain  13 animals were shown to inhibit specifically the activation of 
T  lymphocytes from immune  (2  X  13)F1 guinea pigs,  by antigens  the  response  to 
which is controlled by Ir genes (2).  It was therefore of interest to repeat these studies 
with the monoclonal anti-Ia antibodies. In Fig. 2, we have presented a concentration 
curve of the effects of two monoclonals, 22C4 and 25E 11, on the proliferative responses 
of (2 X  13)F~ T  cells to GL and GT. Monocl0nal antibody 22C4 produced a marked 
inhibition of the proliferative response to GT as well as to PPD, but had no effect on 
the proliferative response to GL- or to PHA-pulsed macrophages. In contrast, mono- 
clonal 25E11 produced a selective inhibition of the T  cell response to GL and had no 
effect on the response to the other antigens or the mitogen PHA. 
In  Table  IV,  we  have  presented  the  results  of studies  performed  with  all  four 
monoclonal antibodies  at  a  final  concentration  of  1/800.  As  seen  in  studies  with 
inbred  strain  13  PEL  (Table  III), only  monoclonals 22C4  and  27E7  produced  a 
marked  inhibition  of the  response  to GT-pulsed  macrophages;  and  as  seen  in  the 
studies  with  strain  2  PEL  (Table  II), only 22C4  failed  to  inhibit  the  proliferative 
response to GL-pulsed macrophages. The proliferative response to PPD, which was 
inhibited  in  both  inbred  strains  by  22C4  and  27E7,  was  also  inhibited  by  these 
monoclonals when F1 cells were tested.  Stimulation by PHA was, as in strain  2 and 
strain  13,  only  inhibited  by  27E7.  Cultivation  in  the  presence  of mixtures  of the 
individual antibodies in several combinations did not lead to any substantial additive 
inhibitory effect. 
Discussion 
One useful approach to the further analysis of the function of the Ia antigens in 
immunocompetent cell  interactions and,  in particular, to the dissection of the rela- 
tionship between Ia antigens and Ir gene products has been to inhibit various in vitro 
assays of T  lymphocyte function with  anti-Ia antibodies.  Our early studies  in  the 
guinea pig that  demonstrated that  anti-Ia antibodies specifically inhibited  the acti- 
vation ofT lymphocytes from immune guinea pigs by antigens, the response to which 
is  controlled  by Ir  genes,  strongly suggested  that  the  Ia  antigens  themselves  were 1018  MONOCLONAL  ANTI-Ia  ANTIBODIES  AND  T  CELL  ACTIVATION 
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F,~.  2.  Inhibition of the proliferative response of (2 ×  13)F= PEL to antigen- or mitogen-pulsed 
PEC.  F]  PEL  (2  ×  10S) were cultured with antigen- or mitogen-pulsed Fj  PEC  (1  ×  10~  in the 
presence of the indicated dilution of 22C4, 25E11, or the control ascites. Results are expressed as the 
percentage of control ['SH]TdR incorporation 
Acpm in anti-la aseites 
=  100× 
Acpm in control ascites" 
TABLE  IV 
Effect of Monoclonal Anti-Ia Antibodies on the Proliferative Response of (2  X  13)Fl PEL 
Stimulus 
GL  GT  PPD  PHA 
Acpm 
22C4  39,300  5,749  44,031  62,440 
25E3  14,011  12,399  82,398  54,577 
25E 11  10,834  13,867  109,836  57,321 
27E7  5,063  6,908  48,438  29,867 
Control ascites  32,507  15,058  95,237  65,438 
(2 X  13)Fi  PEL (2 X  l0  s) were cultured for 3 d  with antigen- or mitogen-pulsed syngeneic PEC (1  ×  105) 
in  the presence of a  1/800  dilution of the anti-la or the control  ascites. Results are expressed as Acpm 
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identical to the products of the lr genes (2).  In general, studies of the effects of anti-Ia 
antibodies on lymphocyte function in vitro have been performed with alloantibodies 
that  represent  a  mixture of different  antibodies  of several subclasses with  different 
biologic properties directed  to an unknown  number of antigenic  determinants on a 
given Ia antigen molecule. It is even possible that some of the available antisera that 
are  defined  as  monospecific on  a  genetic  basis  might  contain  antibodies  to  as  yet 
undefined products of the I region, and that the biological effects of these sera may be 
mediated by interaction with these unknown antigens rather than with what has been 
defined  as  an  Ia  antigen  by  biochemical  criteria.  The  use  of monoclonal  anti-Ia 
antibodies, which exhibit strict specificity and which do not vary in isotype, affinity, 
or  other  biologic  properties,  affords  an  opportunity  to  more  precisely  analyze  the 
effects  of anti-Ia  antibodies  on  T  lymphocyte  activation  in  vitro  and  to  directly 
address some of the objections raised to the use of alloantibodies. 
A  number of investigators have already used monoclonal anti-MHC antibodies to 
inhibit  T  cell  responses  in  vitro.  Thus,  monoclonal  antibodies  to  species-specific 
nonpolymorphic determinants on the HLA-A, -B, and -C chains have been shown to 
inhibit  the  specific  cytotoxic  response  of  human  T  cells  that  were  sensitized  to 
influenza virus-infected cells (12). In contrast, monocional antibodies to polymorphic 
HLA-B determinants failed to inhibit the cytotoxic activity. In the mouse, monoclonal 
antibody  reacting  with  public  speciflcities of H-2K  k  was  shown  to  inhibit  T  cell- 
mediated allogeneic cytotoxicity directed against products of the H-2K  k region and to 
inhibit  the  H-2K~-restricted  cytotoxicity of minor histocompatibility  antigens  (13). 
All of these studies have examined the effects of monoclonal antibodies on cytotoxic 
T  cell function directed to the products of the H-2K and D genes and their analogues 
in other species. Little data are available at present on the effects of monoclonal anti- 
Ia antibodies on T  lymphocyte function. 
We have demonstrated,  with  the aid  of a  highly selective screening system, that 
xenogeneic  monoclonal  antibodies  to  guinea  pig Ia antigens  could  readily be pro- 
duced.  A  detailed  serologic analysis  demonstrated  that  the  monoclonal  antibodies 
recognized either framework determinants shared by both strain  2 and strain  13 Ia 
antigens or alloantigenic determinants of strain 2 Ia antigens. In addition, an analysis 
of the reactivity pattern of the monoclonals with strain 2 Ia antigens suggested that 
a  number  of distinct  determinants  on  strain  2  Ia  antigens  were  identified  by the 
different monoclonal reagents.  2 It was therefore of interest to compare these different 
monoclonal reagents with alloantibodies to Ia antigens with regard to their effects on 
T-lymphocyte proliferation in vitro. 
In the guinea pig MLR (9), as well as in the mouse (14)  and in man (15), it is likely 
that the Ia antigens themselves are the stimulatory antigens because alloantibodies to 
stimulator-, but  not responder-, cell Ia that are present continuously in the cultures 
inhibit  the MLR, and because pretreatment  of macrophages with anti-Ia antibody 
and  complement  results  in  the  inability  of those  cells  remaining  alive  to  act  as 
stimulator cells  (16).  In  general,  the  results of our studies  on  the  inhibition  of the 
MLR  with  the  monoclonal  antibodies  are  consistent  with  this  model.  All  four 
monoclonal  antibodies  tested  reacted  with  strain  2  Ia  antigens  and  all  four  were 
capable of inhibiting  the strain  13  against  strain  2  MLR  by 50-70%.  Similarly,  in 
binding and cytotoxicity assays, only 22C4 and 27E7 were shown to be reactive with 1020  MONOCLONAL ANTI-Ia ANTIBODIES AND T  CELL ACTIVATION 
strain  13 Ia antigens, and only these two monoclonals were capable of inhibiting the 
strain 2 against strain  13 MLR. 
A  number of points should be emphasized about the results of the MLR studies. 
First,  monoclonal  antibodies  25E3  and  25Ell,  which  were  shown  to  be  directed 
against alloantigenic determinants of strain 2 Ia molecules, specifically inhibited the 
strain  13  against  strain  2  MLR,  thus  confirming with  monoclonal  reagents that  Ia 
antigen molecules on stimulator, but not responder, cells are the target antigens for 
inhibition  of  the  MLR.  Second,  although  it  is  difficult  to  directly  compare  the 
monoclonal reagents with alloantibodies, our general impression was that the degree 
of inhibition  of the MLR produced by high concentrations of monoclonal reagents 
was less than that seen with high concentrations of alloantibody. Such a result might 
be anticipated  in  view of the likelihood  that  the  alloantisera  contain  antibodies  to 
multiple determinants on Ia antigen molecules, whereas the monoclonal reagents are 
much more restricted in specificity. However, it was surprising that combinations of 
the monoclonals failed to produce additive inhibitory effects, particularly in view of 
our results that  22C4,  27E7,  and  25E3 recognize distinct  antigenic determinants on 
strain  2  Ia  molecules.  It  should  also  be  noted  that  marked  inhibition  of antigen- 
induced  proliferation  was observed at  dilutions  of the  monoclonals which  failed to 
inhibit the MLR. 
Before  a  detailed  discussion  of the  effects of the  monoclonals  on  antigen-  and 
mitogen-induced T-cell activation can be presented,  it  is appropriate to review our 
previous studies on the effects of alloantibodies on antigen-induced T cell proliferative 
responses.  We  have  previously  shown  that  anti-Ia  sera  directed  against  multiple 
specificities of either the strain 2 or strain  13 I region produced a  marked inhibition 
of the in vitro antigen-induced proliferative response, both to antigens, the response 
to which is under control of specific Ir genes, and to antigens, the response to which 
is not under unigenic control  (1 I);  the proliferative response to PHA-pulsed macro- 
phages was also inhibited by 50-60%. Anti-Ia sera directed to the products of a single 
I  subregion were selective in their inhibitory profile and produced  inhibition  of the 
responses  only  to  antigens  linked  to  the  I  subregion  against  which  the  serum  was 
directed (9). In general, antisera to the product of a single I subregion produced much 
less effect on the proliferative response to complex antigens, such as OVA and PPD, 
than that produced by 13 anti-2 serum or 2 anti-13 serum, which are reactive with all 
the subregions of the strain 2 or strain  13 I regions, respectively (9). 
As all of the monoclonai antibodies  tested behaved differently in their effects on 
antigen-induced  proliferation; we will discuss each antibody or group of antibodies 
separately. Monoclonals 25E3 and 25E11  appeared to be similar to alloantibodies to 
the  Ia.2  antigen  of the  strain  2  I  region  and  specifically inhibited  the  response of 
strain 2 and (2 ×  13)Fa T  cells to GL-pulsed macrophages. Although 25E3 and 25E11 
were not active in immunoprecipitation studies and the molecular characteristics of 
their target antigens were not identified,  the results of the functional studies clearly 
demonstrated that they react with Ia.2. 
The  results  of the  studies  with  monoelonals  27E7  and  22C4,  which  react  with 
determinants present on both strain 2 and strain  13 I  region products, were consid- 
erably more complex. 27E7 inhibited the proliferative response to most antigens tested 
and was the only monoclonal to significantly inhibit the proliferative response to the 
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serum  and  13  anti-2  serum.  It  should  be  emphasized,  however,  that  sequential 
precipitation studies demonstrated that 27E7 was reactive with all the products of the 
strain 13 1 region, but was reactive only with the Ia.2- and not with the Ia.4,5-bearing 
molecule of the strain 2 I region. 
The  results  of the  studies  with  monoclonal  22(24  are  of  greatest  interest.  In 
immunoprecipitation studies, 22(24  appeared to recognize a  framework or common 
determinant  present  on  all  Ia  molecules of both  strain  2  and  strain  13  I  regions. 
However, although 22(24 produced marked inhibition of the proliferative response of 
strain 2 T  lymphocytes to PPD, it failed to produce any inhibition of the response to 
GL. Thus, although 22C4 reacts with the Ia.2-bearing molecule, it does not appear to 
recognize that  part  of the  molecule  that  participates  in  the  presentation  of GL. 
Paradoxically, 22(24 was very effective in inhibiting the response of strain  13 or (2 × 
13)F1 lymphocytes to GT. Thus, because 22C4 was raised against GT nonresponder 
strain 2 cells, we might conclude that a portion of the Ia. 1,6-bearing molecule involved 
in the presentation or recognition of GT on strain  13 cells must  also be present on 
nonresponder strain 2 Ia molecules. Alternatively, we cannot exclude the possibility 
that, as has been shown in murine systems (17), two complementary Ia chains are 
necessary to mount a specific response to GT in strain  13, and that monoclonal 22C4 
identifies a determinant present on one of these chains that is coded for in both strain 
2 and strain  13 1 regions. 
It is likely, as has been reported with antigen-induced T  cell proliferation (18), that 
the monoclonals exert their inhibitory effects by reacting with Ia molecules on the 
antigen-presenting macrophage. We cannot exclude the possibility that some of the 
inhibitory effects of the antibodies might be directed toward the T  cell, because the 
primed guinea pig T  cell responding in vitro in a  secondary proliferation assay has 
been shown to bear Ia antigens with both alloantibodies (19) and monoclonal anti-Ia 
reagents  (R.  Burger and  E. M.  Shevach. Unpublished observations.). However, the 
specific and selective inhibition of T  cell proliferation by the monoclonal antibodies 
argues strongly in favor of the macrophage as the cellular site of their action, because 
no evidence is available that argues for a  participation of Ia antigens at the T  cell 
surface in the specific recognition of antigen. 
The results of our studies with the monoclonals are strongly in favor of the view 
that antibodies to the Ia antigens, rather than antibodies to unique determinants of 
lr gene products, directly mediate the inhibition of T  cell proliferation and that the 
Ia antigens themselves are the products of the Ir genes. Thus, in Fig. 2 we have clearly 
demonstrated with monoclonal antibodies that the proliferative response of (2 ×  13)F1 
lymphocytes to  antigen-pulsed  FI  macrophages  can  be  inhibited  by antibodies  to 
responder, but not nonresponder, parental Ia antigens. This result is identical to that 
of our earlier studies performed with alloantisera (3). 
A number of different mechanisms for the interaction of anti-Ia antibodies with Ia 
antigens on the macrophage surface should be considered. It is possible that anti-Ia 
antibodies lead to a  generalized capping and shedding of Ia antigens and possibly 
associated determinants of the nominal antigen from the macrophage surface; alter- 
natively, the anti-Ia antibodies  may inhibit  the mobility of Ia antigens  in  the cell 
membrane or lead to a  loss  of biological activity of the Ia molecule by altering the 
orientation of the Ia molecule in the membrane required for biological function. The 
results of the studies with monoclonal 27E7, which inhibited the proliferative response 1022  MONOCLONAL  ANTI-Ia ANTIBODIES AND T  CELL ACTIVATION 
to  most  antigens,  the  mitogen  PHA,  and  alloantigens,  are  consistent  with  these 
explanations.  On  the other hand,  the results of the studies with  monoclonal  22C4, 
which  inhibited  the proliferative response to some, but  not  all,  antigens,  suggest  a 
much more specific function  of the Ia antigen  molecule on the cell surface, that  is, 
that  the  monoclonal  antibody might  react  with  different  parts of the  Ia molecules 
that have different functional roles. Certain parts of an Ia molecule might participate 
in the presentation of certain antigens or antigenic  fragments but not others. These 
results are also consistent with the hypothesis proposed by Benacerraf (20)  that states 
that specific Ir gene function dictates the ability of Ia molecules on macrophages to 
interact with antigens, and that Ia antigens on macrophages have a  limited number 
of binding  sites specific for unique  amino acid sequences on antigens.  Thus,  22C4 
fails to react with that portion of the Ia.2 antigen molecule on the macrophage surface 
involved in the recognition or required for presentation of the copolymer GL. A larger 
panel of monoclonal antibodies should enable us to evaluate more fully this hypothesis 
and  to  correlate  directly  the  presence  of a  given  antigenic  determinant  on  an  Ia 
molecule with functional activity in antigen presentation and immunocompetent cell 
interaction. 
Summary 
Four xenogeneic monoclonal antibodies  to guinea pig Ia antigens were tested  for 
their inhibitory effects on antigen-, alloantigen-, and mitogen-induced T  cell prolif- 
eration. All four monoclonal antibodies reacted with strain 2 Ia antigens, and all four 
were capable of inhibiting  the  strain  13  against  strain  2  mixed  leukocyte  reaction 
(MLR) by 50-70%; the two monoclonals that reacted with strain  13 Ia antigens were 
also capable of inhibiting the strain 2 against strain  13 MLR. In contrast, an analysis 
of the effects of a  single  monoclonal  antibody on  the responses to several antigens 
demonstrated a  selective pattern of inhibition  in that the responses to some, but not 
all, antigens were inhibited.  These results suggest  that  monoclonal antibodies react 
with different parts of Ia molecules that may have different functional roles and that 
certain  parts of an  Ia molecule participate  in  the  presentation  of certain  antigens, 
whereas other regions of the same molecule present different antigens. 
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